BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 33060105)

  • 1. Levetiracetam for convulsive status epilepticus in childhood: systematic review and meta-analysis.
    Abdelgadir I; Hamud A; Kadri A; Akram S; Pullattayil A; Akobeng AK; Powell C
    Arch Dis Child; 2020 Oct; ():. PubMed ID: 33060105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Levetiracetam as an alternative to phenytoin for second-line emergency treatment of children with convulsive status epilepticus: the EcLiPSE RCT.
    Appleton RE; Rainford NE; Gamble C; Messahel S; Humphreys A; Hickey H; Woolfall K; Roper L; Noblet J; Lee E; Potter S; Tate P; Al Najjar N; Iyer A; Evans V; Lyttle MD
    Health Technol Assess; 2020 Nov; 24(58):1-96. PubMed ID: 33190679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and Safety of Levetiracetam vs. Phenytoin as Second Line Antiseizure Medication for Pediatric Convulsive Status Epilepticus: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Angurana SK; Suthar R
    J Trop Pediatr; 2021 May; 67(2):. PubMed ID: 34089322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A multicentre randomised controlled trial of levetiracetam versus phenytoin for convulsive status epilepticus in children (protocol): Convulsive Status Epilepticus Paediatric Trial (ConSEPT) - a PREDICT study.
    Dalziel SR; Furyk J; Bonisch M; Oakley E; Borland M; Neutze J; Donath S; Sharpe C; Harvey S; Davidson A; Craig S; Phillips N; George S; Rao A; Cheng N; Zhang M; Sinn K; Kochar A; Brabyn C; Babl FE;
    BMC Pediatr; 2017 Jun; 17(1):152. PubMed ID: 28641582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Levetiracetam Versus Phenytoin or Fosphenytoin for Second-Line Treatment of Pediatric Status Epilepticus: A Meta-Analysis.
    Klowak JA; Hewitt M; Catenacci V; Duffett M; Rochwerg B; Jones K; Choong K
    Pediatr Crit Care Med; 2021 Sep; 22(9):e480-e491. PubMed ID: 33710073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of levetiracetam versus (fos)phenytoin for second-line treatment of epilepticus: a meta-analysis of latest randomized controlled trials.
    Feng Y; Chen Y; Jia Y; Wang Z; Wang X; Jiang L; Ai C; Li W; Liu Y
    Seizure; 2021 Oct; 91():339-345. PubMed ID: 34284302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emergency treatment with levetiracetam or phenytoin in status epilepticus in children-the EcLiPSE study: study protocol for a randomised controlled trial.
    Lyttle MD; Gamble C; Messahel S; Hickey H; Iyer A; Woolfall K; Humphreys A; Bacon NEA; Roper L; Babl FE; Dalziel SR; Ryan M; Appleton RE;
    Trials; 2017 Jun; 18(1):283. PubMed ID: 28629473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety profile of intravenous levetiracetam versus phenytoin in convulsive status epilepticus and acute repetitive seizures in children.
    Besli GE; Yuksel Karatoprak E; Yilmaz S
    Epilepsy Behav; 2020 Oct; 111():107289. PubMed ID: 32702655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of levetiracetam, fosphenytoin, and valproate for established status epilepticus by age group (ESETT): a double-blind, responsive-adaptive, randomised controlled trial.
    Chamberlain JM; Kapur J; Shinnar S; Elm J; Holsti M; Babcock L; Rogers A; Barsan W; Cloyd J; Lowenstein D; Bleck TP; Conwit R; Meinzer C; Cock H; Fountain NB; Underwood E; Connor JT; Silbergleit R; ;
    Lancet; 2020 Apr; 395(10231):1217-1224. PubMed ID: 32203691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pre-hospital and emergency department treatment of convulsive status epilepticus in adults: an evidence synthesis.
    Cruickshank M; Imamura M; Booth C; Aucott L; Counsell C; Manson P; Scotland G; Brazzelli M
    Health Technol Assess; 2022 Mar; 26(20):1-76. PubMed ID: 35333156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Levetiracetam versus phenytoin for second-line treatment of paediatric convulsive status epilepticus (EcLiPSE): a multicentre, open-label, randomised trial.
    Lyttle MD; Rainford NEA; Gamble C; Messahel S; Humphreys A; Hickey H; Woolfall K; Roper L; Noblet J; Lee ED; Potter S; Tate P; Iyer A; Evans V; Appleton RE;
    Lancet; 2019 May; 393(10186):2125-2134. PubMed ID: 31005385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Levetiracetam vs. phenytoin as 2nd-line treatment for status epilepticus: A systematic review and meta-analysis.
    DeMott JM; Slocum GW; Gottlieb M; Peksa GD
    Epilepsy Behav; 2020 Oct; 111():107286. PubMed ID: 32707535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Levetiracetam versus Fosphenytoin in Pediatric Convulsive Status Epilepticus: A Randomized Controlled Trial.
    Handral A; Veerappa BG; Gowda VK; Shivappa SK; Benakappa N; Benakappa A
    J Pediatr Neurosci; 2020; 15(3):252-256. PubMed ID: 33531940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticonvulsant therapy for status epilepticus.
    Prasad M; Krishnan PR; Sequeira R; Al-Roomi K
    Cochrane Database Syst Rev; 2014 Sep; 2014(9):CD003723. PubMed ID: 25207925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Levetiracetam versus phenytoin for the treatment of established status epilepticus: A systematic review and meta-analysis of randomized controlled trials.
    Li L; Zhang Y; Jia L; Jia D; Faramand A; Chong W; Fang Y; Ma L; Fang F
    Seizure; 2020 May; 78():43-48. PubMed ID: 32182544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Levetiracetam versus fosphenytoin as a second-line treatment after diazepam for status epilepticus: study protocol for a multicenter non-inferiority designed randomized control trial.
    Nakamura K; Marushima A; Takahashi Y; Kimura A; Asami M; Egawa S; Kaneko J; Kondo Y; Yonekawa C; Hoshiyama E; Yamada T; Maruo K; Inoue Y;
    Trials; 2021 May; 22(1):317. PubMed ID: 33934714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized Trial of Three Anticonvulsant Medications for Status Epilepticus.
    Kapur J; Elm J; Chamberlain JM; Barsan W; Cloyd J; Lowenstein D; Shinnar S; Conwit R; Meinzer C; Cock H; Fountain N; Connor JT; Silbergleit R;
    N Engl J Med; 2019 Nov; 381(22):2103-2113. PubMed ID: 31774955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological treatments for preventing epilepsy following traumatic head injury.
    Thompson K; Pohlmann-Eden B; Campbell LA; Abel H
    Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD009900. PubMed ID: 26259048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Levetiracetam versus phenytoin for second-line treatment of convulsive status epilepticus in children (ConSEPT): an open-label, multicentre, randomised controlled trial.
    Dalziel SR; Borland ML; Furyk J; Bonisch M; Neutze J; Donath S; Francis KL; Sharpe C; Harvey AS; Davidson A; Craig S; Phillips N; George S; Rao A; Cheng N; Zhang M; Kochar A; Brabyn C; Oakley E; Babl FE;
    Lancet; 2019 May; 393(10186):2135-2145. PubMed ID: 31005386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Levetiracetam versus Phenytoin for the Pharmacotherapy of Benzodiazepine-Refractory Status Epilepticus: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Xue T; Wei L; Shen X; Wang Z; Chen Z; Wang Z
    CNS Drugs; 2020 Dec; 34(12):1205-1215. PubMed ID: 33111213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.